Syndax Pharmaceuticals (SNDX) Work In Process (2024 - 2026)

Syndax Pharmaceuticals' Work In Process history runs 3 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Work In Process rose 401.57% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 401.57% YoY), while the FY2025 annual figure was $2.1 million, up 540.0% from the prior year.
• Work In Process for Q1 2026 stood at $2.9 million, up from $2.1 million in the prior quarter.
• The five-year high for Work In Process was $2.9 million in Q1 2026, with the low at $330000.0 in Q4 2024.
• The 3-year median for Work In Process is $1.3 million (2025), against an average of $1.4 million.
• The sharpest annual moves came in 2025 and 2026: Work In Process surged 540.0% in 2025, then surged 401.57% in 2026.
• Syndax Pharmaceuticals' Work In Process stood at $330000.0 in 2024, then soared by 540.0% to $2.1 million in 2025, then surged by 35.84% to $2.9 million in 2026.
• Business Quant data shows SNDX's Work In Process at $2.9 million in Q1 2026, $2.1 million in Q4 2025, and $1.4 million in Q3 2025.